https://speakerdeck.com/xtalks 2026-08-24 11:17:38 -0400 Most oncology strategies are shaped by evidence and infrastructure that is built and measured in academic centers. Yet most patients are treated in community oncology settings, where biopsy timing, tissue adequacy, turnaround time for molecular results, payer utilization management and social determinants of health (SDOH) can determine whether precision medicine is delivered consistently. This nine-slide deck asks the readiness questions every life sciences team working in oncology should be able to answer. Does your evidence plan reflect how community oncology actually works? Which test answers the clinical question — NGS panel, focused assay or liquid biopsy? Can ordering and interpretation hold together across multidisciplinary teams? What do payer requirements do to your timeline from result to treatment? And are social determinants of health measured, or treated as background? It closes with three ideas from a community test-to-treat playbook: the real-world levers of precision oncology uptake, testing chosen well and SDOH as measurable factors. There is far more to the test-to-treat story than fits in nine slides. Go deeper in the free Xtalks webinar "Improve Precision Medicine Timelines in Community Oncology Care," which aired June 4, 2026 — the full 60-minute recording is available on demand with free registration. Webinar attendees will learn the real-world levers that determine precision oncology uptake in community settings, how measurable SDOH factors change outcomes and evidence plans in underserved community cohorts undergoing advanced genomic testing and executive decisions about liquid biopsy implementation, inclusive evidence generation and scalable access strategies for therapies and diagnostics. Register free to watch the recording on demand: https://xtalks.com/webinars/improve-precision-medicine-timelines-in-community-oncology-care/?utm_source=slideshare&utm_medium=promodeck Most oncology strategies are shaped by evidence and infrastructure that is built and measured in academic centers. Yet most patients are treated in community oncology settings, where biopsy timing, tissue adequacy, turnaround time for molecular results, payer utilization management and social determinants of health (SDOH) can determine whether precision medicine is delivered consistently. This nine-slide deck asks the readiness questions every life sciences team working in oncology should be able to answer. Does your evidence plan reflect how community oncology actually works? Which test answers the clinical question — NGS panel, focused assay or liquid biopsy? Can ordering and interpretation hold together across multidisciplinary teams? What do payer requirements do to your timeline from result to treatment? And are social determinants of health measured, or treated as background? It closes with three ideas from a community test-to-treat playbook: the real-world levers of precision oncology uptake, testing chosen well and SDOH as measurable factors. There is far more to the test-to-treat story than fits in nine slides. Go deeper in the free Xtalks webinar "Improve Precision Medicine Timelines in Community Oncology Care," which aired June 4, 2026 — the full 60-minute recording is available on demand with free registration. Webinar attendees will learn the real-world levers that determine precision oncology uptake in community settings, how measurable SDOH factors change outcomes and evidence plans in underserved community cohorts undergoing advanced genomic testing and executive decisions about liquid biopsy implementation, inclusive evidence generation and scalable access strategies for therapies and diagnostics. Register free to watch the recording on demand: https://xtalks.com/webinars/improve-precision-medicine-timelines-in-community-oncology-care/?utm_source=slideshare&utm_medium=promodeck Mon, 24 Aug 2026 00:00:00 -0400 https://speakerdeck.com/xtalks/precision-medicine-in-community-oncology https://speakerdeck.com/xtalks/precision-medicine-in-community-oncology Disruption is no longer the exception. It's the operating environment. Geopolitical shocks, extreme weather, supplier failures and shifting demand test even the most carefully built life sciences supply chains every day — yet 57% of companies still take more than a week to learn about a disruption in their network. By then, the business impact may already be underway. This nine-slide deck asks the readiness questions every life sciences supply chain team should be able to answer. When your life science network is disrupted, how long is it before you know? How far across your extended supplier base can you actually see? Where does disruption data live today, and who sees it first? And when a shock hits, who coordinates action across every partner? It closes with three ideas that separate resilient distribution networks: resilience by design, signals worth capturing and one connected response. There is far more to network resilience than fits in nine slides. Go deeper in the free Xtalks webinar "Reduce Life Sciences Supply Chain Risk with Faster Response," live Tuesday, October 27, 2026 at 11am EDT (NA) / 3pm GMT (UK) / 4pm CET (EU-Central), 60 min. Webinar attendees will learn what makes distribution networks resilient and better able to respond to disruption, how disruption data can be captured across an extended supplier base and a framework for connecting those signals into a supply chain network with a command center that manages disruptions, drives responses and executes plans from supplier to CMO to distribution and hospitals. Disruption is no longer the exception. It's the operating environment. Geopolitical shocks, extreme weather, supplier failures and shifting demand test even the most carefully built life sciences supply chains every day — yet 57% of companies still take more than a week to learn about a disruption in their network. By then, the business impact may already be underway. This nine-slide deck asks the readiness questions every life sciences supply chain team should be able to answer. When your life science network is disrupted, how long is it before you know? How far across your extended supplier base can you actually see? Where does disruption data live today, and who sees it first? And when a shock hits, who coordinates action across every partner? It closes with three ideas that separate resilient distribution networks: resilience by design, signals worth capturing and one connected response. There is far more to network resilience than fits in nine slides. Go deeper in the free Xtalks webinar "Reduce Life Sciences Supply Chain Risk with Faster Response," live Tuesday, October 27, 2026 at 11am EDT (NA) / 3pm GMT (UK) / 4pm CET (EU-Central), 60 min. Webinar attendees will learn what makes distribution networks resilient and better able to respond to disruption, how disruption data can be captured across an extended supplier base and a framework for connecting those signals into a supply chain network with a command center that manages disruptions, drives responses and executes plans from supplier to CMO to distribution and hospitals. Mon, 24 Aug 2026 00:00:00 -0400 https://speakerdeck.com/xtalks/enhancing-resilience-in-pharma-manufacturing-and-supply-chains-amid-disruption https://speakerdeck.com/xtalks/enhancing-resilience-in-pharma-manufacturing-and-supply-chains-amid-disruption